HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factors correlated with early and late recurrence after curative gastrectomy for gastric cancer.

AbstractBACKGROUND/AIMS:
The objective of the present study was to establish an effective follow-up method to analyze the features of patients who relapsed after curative gastrectomy.
METHODOLOGY:
At the Department of General Surgical Science, Gunma University, 44 of 321 patients who underwent curative gastrectomy for gastric cancer from 2002 to 2006 were found to relapse. The patients were divided into an early-recurrence group (n = 23; relapse within one year of gastrectomy) and a late-recurrence group (n = 21; relapse one year or more after gastrectomy). The clinicopathological features were examined.
RESULTS:
The patients in the early-recurrence group were characterized by a high level of lymph node metastases (> or = N2), Stage IIIB, and the presence of vascular invasion (v2, v3). On a multiple logistic regression analysis, the depth of wall invasion (> or = T3), level of lymph node metastases (> or = N2), and degree of vascular invasion (v2, v3) were significantly correlated with recurrence within one year of gastrectomy.
CONCLUSIONS:
Careful follow-up including frequent imaging diagnosis, e.g., using computed tomography (CT), is required for patients with a high risk of recurrence.
AuthorsKyoichi Ogata, Erito Mochiki, Mitsuhiro Yanai, Yoshitaka Toyomasu, Hiroyuki Ando, Tetsuro Ohno, Ryuusuke Aihara, Takayuki Asao, Hiroyuki Kuwano
JournalHepato-gastroenterology (Hepatogastroenterology) 2009 Nov-Dec Vol. 56 Issue 96 Pg. 1760-4 ISSN: 0172-6390 [Print] Greece
PMID20214233 (Publication Type: Journal Article)
Chemical References
  • Carcinoembryonic Antigen
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoembryonic Antigen (analysis)
  • Female
  • Gastrectomy
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Stomach Neoplasms (mortality, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: